Product Images Donepezil Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 12 images provide visual information about the product associated with Donepezil Hydrochloride NDC 33261-817 by Aidarex Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
structural - donepezil hcl 10mg tab for pliva 1
Donepezil Hydrochloride Figure 9 - donepezil hcl 10mg tab for pliva 10
This appears to be a table showing the effects of donepezil hydrochloride, a medication often used to treat Alzheimer's disease. It looks like the drug showed some improvement compared to a placebo group when administered at a dose of 10mg per day, with some clinical decline observed as well. The rest of the information in the table is not legible.*
Donepezil Hydrochloride Figure 10 - donepezil hcl 10mg tab for pliva 11
IMAGE LABEL - donepezil hcl 10mg tab for pliva 12
This is a description of a medicine package containing Donepezil HCL 10mg tablets. The package contains 30 round, yellow, film-coated tablets imprinted with "TEVA" on one side and "739" on the other side. The tablets are a generic version of a medication called Aricept and are used to treat Alzheimer's disease. The manufacturer of the medication is Aidarex Pharmaceuticals LLC and the National Drug Code (NDC) for this product is 33281-0817-30. The package was made in Croatia.*
Donepezil Hydrochloride Figure 1 - donepezil hcl 10mg tab for pliva 2
Donepezil Hydrochloride Figure 2 - donepezil hcl 10mg tab for pliva 3
This text appears to be a chart or graph displaying the cumulative percentage of patients and their change in ADAS-cog score after taking different dosages of Danepeziyshochirce and Placebo for 15 days. The different dosages are 0mg, 5mg/day, and 10mg/day. The graph demonstrates that Danepeziyshochirce has a positive effect on the ADAS-cog score for all dosages when compared to the Placebo group.*
Donepezil Hydrochloride Figure 3 - donepezil hcl 10mg tab for pliva 4
Donepezil Hydrochloride Figure 4 - donepezil hcl 10mg tab for pliva 5
Donepezil Hydrochloride Figure 5 - donepezil hcl 10mg tab for pliva 6
This appears to be a table displaying data on the treatment of patients using various dosages of Donepezil Hydrochloride for dementia. The table displays the change in ADAS-cog scores for patients who received the drug compared to those who received a placebo. However, without more context or data, the information is limited.*
Donepezil Hydrochloride Figure 6 - donepezil hcl 10mg tab for pliva 7
This appears to be a table or chart with a title "GIBIC plus Rating" and some data points. It is unclear what the data pertains to or what the units of measurement are. Therefore, without further context or information, it is not possible to provide a useful description.*
Donepezil Hydrochloride Figure 7 - donepezil hcl 10mg tab for pliva 8
This appears to be a graph displaying the clinical improvement or decline in a study comparing the effects of Donepezil hydrochloride (10mg/day) versus a placebo over a period of 24 weeks. The axis on the left measures improvement or decline with a range of -30 to 30 and the axis on the bottom measures the weeks of the study.*
Donepezil Hydrochloride Figure 8 - donepezil hcl 10mg tab for pliva 9
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.